To the Editor: We agree with Stockigt that clinical accountability is needed in the production of consumer medicines information (CMI).1 However, providing CMI is a great deal more complex. The ways in which consumers access and absorb medical information are still largely unknown, and the most important issue is potentially that consumers are not receiving CMI.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Stockigt JR. The quality of medication information in Australia: the need for more clinical expertise and accountability [editorial]. Med J Aust 2009; 190: 110-111. <MJA full text>
- 2. Nilsen ES, Myrhaug HT, Johansen M, et al. Methods of consumer involvement in developing healthcare policy and research, clinical practice guidelines and patient information material. Cochrane Database Syst Rev 2006; (3): CD004563. DOI: 10.1002/14651858.CD004563.pub2.
- 3. Telford R, Boote JD, Cooper CL. What does it mean to involve consumers successfully in NHS research? A consensus study. Health Expect 2004; 7: 209-220.
- 4. Vitry A, Gilbert A, Mott K, et al. Provision of medicines information in Australian community pharmacies. Pharm World Sci 2009; 31: 154-157. DOI: 10. 1007/s11096-009-9285-0.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
We acknowledge the input of the expert panel throughout the course of the study and funding for the study from the NHMRC.